MedTrace Logo

Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting

NCT05143554 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2025-09-26

No results posted yet for this study

Summary

This study evaluates the efficacy of auricular percutaneous electrical nerve field stimulator in children, adolescents and young adults with chemotherapy induced nausea and vomiting.

Conditions

  • Chemotherapy-induced Nausea and Vomiting

Interventions

DEVICE

Auricular percutaneous neurostimulation

Percutaneous neurostimulation

DEVICE

Sham percutaneous neurostimulation

Sham percutaneous neurostimulation

Sponsors & Collaborators

  • Medical College of Wisconsin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
4 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2025-09-23
Completion
2025-09-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05143554 on ClinicalTrials.gov